title: Reduced albumin binding of MADDS--a measure of bilirubin binding--during pregnancy and delivery.
abstract: It was the purpose of the present study to investigate whether the decrease in the ability of plasma albumin to bind bilirubin, noted in pregnancy and during delivery, takes place in one step, during pregnancy alone, or in two steps, during both pregnancy and delivery. Furthermore, it was investigated whether a possible decrease during labor was related to the method of delivery itself. The material comprised (a) 17 pregnant women who delivered vaginally; (b) 25 women who were delivered by Cesarean Section; and (c) a group of 25 non-pregnant women. The reserve albumin concentration for binding of MADDS (a measure of the binding of unconjugated bilirubin), the total albumin concentration and the ratio between them were constant in the 6-week period up to birth and were significantly lower than the corresponding values in the non-pregnant group. During labor a significant decrease in reserve albumin and ratio of reserve albumin to total albumin was observed, while no change in the total albumin concentration was noted. No significant difference in reserve albumin concentration, total albumin concentration and ratio between them was found when the group of mothers who delivered vaginally was compared to the Cesarean Section group. It is concluded that the decrease in the ability of plasma albumin to bind unconjugated bilirubin takes place stepwise. The first step is a significant reduction during pregnancy followed by a further decrease during labor. The method of delivery is of no significance.
authors.affiliation: Department of Gynecology & Obstetrics, University Hospital of Aalborg, Denmark.
authors.forename: F
authors.initials: F
authors.lastname: Ebbesen
authors.forename: A
authors.initials: A
authors.lastname: Knudsen
authors.forename: P L
authors.initials: PL
authors.lastname: Petersen
mesh_terms: D001663:Bilirubin / Q000097:blood*; D001667:Binding, Competitive; D002585:Cesarean Section; D003622:Dapsone / Q000031:analogs & derivatives* / Q000097:blood; D036861:Delivery, Obstetric; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007743:Labor, Obstetric; D011247:Pregnancy / Q000097:blood*; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism*
chemical_list: D012709:Serum Albumin; D003622:Dapsone; C018965:monoacetyldapsone; D001663:Bilirubin